Anemia, Refractory - 368 Studies Found
Completed |
: Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome :
|
Recruiting |
: Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies :
: |
Active, not recruiting |
: Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders :
: |
Completed |
: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies :
: |
Completed |
: MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia :
|
Completed |
: Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies :
|
Completed |
: Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia :
: 2006-01-16 : |
Completed |
: Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies :
|
Completed |
: Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T :
|
Terminated |
: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler :
|